Antitumor activity of DNA vaccines based on the human papillomavirus-16 E7 protein genetically fused to a plant virus coat protein.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 18439124)

Published in Hum Gene Ther on April 01, 2008

Authors

Silvia Massa1, Paola Simeone, Antonio Muller, Eugenio Benvenuto, Aldo Venuti, Rosella Franconi

Author Affiliations

1: Biotechnologies, Agro-Industry and Health Protection Department, Italian National Agency for New Technologies, Energy, and the Environment, ENEA C.R. Casaccia, 00123 Rome, Italy.

Articles citing this

Immunotherapy for cervical cancer: Research status and clinical potential. BioDrugs (2010) 1.18

Therapeutic HPV DNA vaccines. Immunol Res (2010) 1.12

Perspectives for preventive and therapeutic HPV vaccines. J Formos Med Assoc (2010) 0.99

Immunologic treatments for precancerous lesions and uterine cervical cancer. J Exp Clin Cancer Res (2014) 0.96

Therapeutic HPV DNA vaccines. Expert Rev Vaccines (2009) 0.90

Genetic engineering and chemical conjugation of potato virus X. Methods Mol Biol (2014) 0.85

Progress and challenges in the vaccine-based treatment of head and neck cancers. J Exp Clin Cancer Res (2009) 0.81

Immunotherapy in new pre-clinical models of HPV-associated oral cancers. Hum Vaccin Immunother (2013) 0.80

Plant Viruses as Nanoparticle-Based Vaccines and Adjuvants. Vaccines (Basel) (2015) 0.79

Anti-tumor effects of genetic vaccines against HPV major oncogenes. Hum Vaccin Immunother (2014) 0.78

Fowlpox virus recombinants expressing HPV-16 E6 and E7 oncogenes for the therapy of cervical carcinoma elicit humoral and cell-mediated responses in rabbits. J Transl Med (2010) 0.78

Perspective for prophylaxis and treatment of cervical cancer: an immunological approach. Int Rev Immunol (2012) 0.77

A prime/boost strategy using DNA/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancers. J Transl Med (2015) 0.77

Recombinant HPV16 E7 assembled into particles induces an immune response and specific tumour protection administered without adjuvant in an animal model. J Transl Med (2011) 0.77

Immunotherapy of HPV-associated cancer: DNA/plant-derived vaccines and new orthotopic mouse models. Cancer Immunol Immunother (2015) 0.76

HPV 16 E5 oncoprotein is expressed in early stage carcinogenesis and can be a target of immunotherapy. Hum Vaccin Immunother (2016) 0.75

A plant protein signal sequence improved humoral immune response to HPV prophylactic and therapeutic DNA vaccines. Hum Vaccin Immunother (2017) 0.75

Production of Japanese Encephalitis Virus Antigens in Plants Using Bamboo Mosaic Virus-Based Vector. Front Microbiol (2017) 0.75

Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation. Int J Nanomedicine (2017) 0.75

Articles by these authors

Identification of putative stage-specific grapevine berry biomarkers and omics data integration into networks. Plant Physiol (2010) 1.32

Transient expression systems for plant-derived biopharmaceuticals. Expert Rev Vaccines (2010) 1.22

A late complication of pelvic radiotherapy: leiomyosarcoma of the rectum. Report of a case and review of the literature. Hepatogastroenterology (2003) 1.09

Both mucosal and cutaneous papillomaviruses are in the oral cavity but only alpha genus seems to be associated with cancer. J Clin Virol (2012) 1.07

Strawberry proteome characterization and its regulation during fruit ripening and in different genotypes. J Proteomics (2008) 1.06

An E7-based therapeutic vaccine protects mice against HPV16 associated cancer. Vaccine (2009) 1.06

Plant pharming of a full-sized, tumour-targeting antibody using different expression strategies. Plant Biotechnol J (2008) 1.04

Therapeutic targeting of the endothelin a receptor in human ovarian carcinoma. Cancer Res (2003) 1.03

Detection of bovine papillomavirus type 2 in the peripheral blood of cattle with urinary bladder tumours: possible biological role. J Gen Virol (2008) 1.03

HPV16 and HPV18 in genital tumors: Significantly different levels of viral integration and correlation to tumor invasiveness. J Med Virol (2002) 1.03

HPV vaccine: an overview of immune response, clinical protection, and new approaches for the future. J Transl Med (2010) 1.03

Presence of bovine papillomavirus type 2 DNA and expression of the viral oncoprotein E5 in naturally occurring urinary bladder tumours in cows. J Gen Virol (2003) 1.01

Anti-cancer activity of plant-produced HPV16 E7 vaccine. Vaccine (2007) 0.99

Growth inhibition of cervix carcinoma cells in vivo by endothelin A receptor blockade. Cancer Res (2002) 0.98

Molecular analyses and prognostic relevance of HPV in head and neck tumours. Oncol Rep (2007) 0.98

PBMCs are additional sites of productive infection of bovine papillomavirus type 2. J Gen Virol (2011) 0.97

The human immunodeficiency virus antigen Nef forms protein bodies in leaves of transgenic tobacco when fused to zeolin. J Exp Bot (2008) 0.94

Human Papillomaviruses, p16INK4a and Akt expression in basal cell carcinoma. J Exp Clin Cancer Res (2011) 0.94

Human papillomavirus vaccines in plants. Expert Rev Vaccines (2010) 0.93

Peptide display on Potato virus X: molecular features of the coat protein-fused peptide affecting cell-to-cell and phloem movement of chimeric virus particles. J Gen Virol (2006) 0.93

The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis. Int J Biol Markers (2009) 0.93

Merkel cell polyomavirus in Merkel cell carcinoma of Italian patients. Virol J (2011) 0.91

Plant-derived human papillomavirus 16 E7 oncoprotein induces immune response and specific tumor protection. Cancer Res (2002) 0.90

Two-dimensional differential in gel electrophoresis (2D-DIGE) analysis of grape berry proteome during postharvest withering. J Proteome Res (2010) 0.90

Engineering stable cytoplasmic intrabodies with designed specificity. J Mol Biol (2003) 0.89

Validation of a stable recombinant antibodies repertoire for the direct selection of functional intracellular reagents. J Immunol Methods (2007) 0.88

High-level HIV-1 Nef transient expression in Nicotiana benthamiana using the P19 gene silencing suppressor protein of Artichoke Mottled Crinckle Virus. BMC Biotechnol (2009) 0.87

Expression, intracellular targeting and purification of HIV Nef variants in tobacco cells. BMC Biotechnol (2007) 0.87

Site-specific proteolytic degradation of IgG monoclonal antibodies expressed in tobacco plants. Plant Biotechnol J (2014) 0.86

Proteomic analysis of the plant-virus interaction in cucumber mosaic virus (CMV) resistant transgenic tomato. J Proteome Res (2010) 0.86

Plant-produced potato virus X chimeric particles displaying an influenza virus-derived peptide activate specific CD8+ T cells in mice. Vaccine (2009) 0.86

Is desmoplasia a protective factor for survival in patients with colorectal carcinoma? Clin Gastroenterol Hepatol (2005) 0.85

Plant-based strategies aimed at expressing HIV antigens and neutralizing antibodies at high levels. Nef as a case study. Transgenic Res (2009) 0.85

In vivo antitumor effect of an intracellular single-chain antibody fragment against the E7 oncoprotein of human papillomavirus 16. Int J Cancer (2013) 0.84

Bovine papillomavirus type-2 DNA and expression of E5 and E7 oncoproteins in vascular tumours of the urinary bladder in cattle. Cancer Lett (2006) 0.84

Potato virus X movement in Nicotiana benthamiana: new details revealed by chimeric coat protein variants. Mol Plant Pathol (2011) 0.83

Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting. Mol Immunol (2008) 0.83

Mutants of plant genes for developing cancer vaccines. Hum Vaccin (2011) 0.82

Production of an engineered killer peptide in Nicotiana benthamiana by using a potato virus X expression system. Appl Environ Microbiol (2005) 0.82

Recent insights into plant-virus interactions through proteomic analysis. J Proteome Res (2012) 0.82

In vivo HPV 16 E5 mRNA: expression pattern in patients with squamous intra-epithelial lesions of the cervix. J Clin Virol (2011) 0.82

UVB irradiation down-regulates HPV-16 RNA expression: implications for malignant progression of transformed cells. Virus Res (2007) 0.81

Detection of HPV-15 in painful subungual tumors of incontinentia pigmenti: successful topical therapy with retinoic acid. Eur J Dermatol (2009) 0.80

Immunotherapy in new pre-clinical models of HPV-associated oral cancers. Hum Vaccin Immunother (2013) 0.80

Plant production of anti-β-glucan antibodies for immunotherapy of fungal infections in humans. Plant Biotechnol J (2011) 0.80

A Chlamydomonas-derived Human Papillomavirus 16 E7 vaccine induces specific tumor protection. PLoS One (2013) 0.80

Human papillomavirus type 5 in primary keratinocytes from psoriatic skin. Exp Dermatol (2005) 0.80

Optimisation of the purification process of a tumour-targeting antibody produced in N. benthamiana using vacuum-agroinfiltration. Transgenic Res (2010) 0.80

Production of different glycosylation variants of the tumour-targeting mAb H10 in Nicotiana benthamiana: influence on expression yield and antibody degradation. Transgenic Res (2012) 0.80

Plant heat shock protein 70 as carrier for immunization against a plant-expressed reporter antigen. Transgenic Res (2010) 0.80

Human papillomavirus therapeutic vaccines in head and neck tumors. Expert Rev Anticancer Ther (2007) 0.80

Leaf proteome analysis of transgenic plants expressing antiviral antibodies. J Proteome Res (2009) 0.79

Efficient Agrobacterium-based transient expression system for the production of biopharmaceuticals in plants. Bioeng Bugs (2010) 0.79

Structure-based design and experimental engineering of a plant virus nanoparticle for the presentation of immunogenic epitopes and as a drug carrier. J Biomol Struct Dyn (2013) 0.79

A prime/boost strategy by DNA/fowlpox recombinants expressing a mutant E7 protein for the immunotherapy of HPV-associated cancers. Virus Res (2012) 0.79

1st International Workshop on Papillomavirus E5 Oncogene-a report. Virology (2010) 0.78

Interaction between glutathione-S-transferase polymorphisms, smoking habit, and HPV infection in cervical cancer risk. J Cancer Res Clin Oncol (2010) 0.78

Identification of episomal human papillomavirus and other DNA viruses in cytological anal samples of HIV-uninfected men who have sex with men. PLoS One (2013) 0.78

Anti-tumor effects of genetic vaccines against HPV major oncogenes. Hum Vaccin Immunother (2014) 0.78

Gastric cancer precursor lesions and Helicobacter pylori infection in patients with partial gastrectomy for peptic ulcer. World J Surg (2005) 0.78

2-D DIGE analysis of UV-C radiation-responsive proteins in globe artichoke leaves. Proteomics (2012) 0.77

Musarmins: three single-chain ribosome-inactivating protein isoforms from bulbs of Muscari armeniacum L. and Miller. Int J Biochem Cell Biol (2003) 0.77

Targeting endothelin receptor type A in human cervical carcinoma cells. J Cardiovasc Pharmacol (2004) 0.77

DNA vaccines against HPV-16 E7-expressing tumour cells. Anticancer Res (2003) 0.77

Heat-shock protein 70 from plant biofactories of recombinant antigens activate multiepitope-targeted immune responses. Plant Biotechnol J (2012) 0.77

Further good news from prophylactic human papillomavirus vaccines: long-term duration of immunity. Womens Health (Lond Engl) (2010) 0.76

Physical status of HPV types 16 and 18 in topographically different areas of genital tumours and in paired tumour-free mucosa. Int J Oncol (2005) 0.76

Increased circulating resistin is associated with insulin resistance, oxidative stress and platelet activation in type 2 diabetes mellitus. Thromb Haemost (2016) 0.76

LC-MS/MS methods for absolute quantification and identification of proteins associated with chimeric plant oil bodies. Anal Chem (2011) 0.76

Immunomodulation of cucumber mosaic virus infection by intrabodies selected in vitro from a stable single-framework phage display library. Plant Mol Biol (2005) 0.76

Coagulation and infective endocarditis: sooner or later. Intern Emerg Med (2015) 0.75

Persistence of HPV after radio-chemotherapy in locally advanced cervical cancer. Oncol Rep (2010) 0.75

ABT-627, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma growth in vitro. Clin Sci (Lond) (2002) 0.75

Endothelin receptor blockade inhibits the growth of human papillomavirus-associated cervical carcinoma. Clin Sci (Lond) (2002) 0.75

Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: effects of anti-TNF-α treatment. Thromb Haemost (2016) 0.75

High-intensity static magnetic field exposure devices for in vitro experiments on biopharmaceutical plant factories in aerospace environments. Conf Proc IEEE Eng Med Biol Soc (2015) 0.75

Kerinokeratosis papulosa-like lesions in an adult man with homozygous polymorphism of EVER 2. Eur J Dermatol (2011) 0.75

True aneurysm of the ulnar artery in a soccer goalkeeper: a case report and surgical considerations. Am J Sports Med (2003) 0.75